BeOne Medicines (ONC) Shares Outstanding (2015 - 2020)

BeOne Medicines (ONC) has 5 years of Shares Outstanding data on file, last reported at $1.0 billion in Q1 2020.

• Quarterly Shares Outstanding changed N/A year-over-year to $1.0 billion in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $1.0 billion (changed N/A YoY) and the FY2018 annual result came in at $776.3 million, up 31.11% from the prior year.
• Shares Outstanding grew to $1.0 billion in Q1 2020 per ONC's latest filing, from $776.3 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $1.0 billion in Q1 2020 and bottomed at $427.4 million in Q1 2016.
• The 4-year median for Shares Outstanding is $554.3 million (2017), against an average of $600.3 million.
• The widest annual swing landed in 2016, when Shares Outstanding surged 344.02%; it then rose 14.78% in 2017.
• Tracing ONC's Shares Outstanding over 4 years: stood at $515.8 million in 2016, then advanced by 14.78% to $592.1 million in 2017, then jumped by 31.11% to $776.3 million in 2018, then increased by 29.85% to $1.0 billion in 2020.
• Per Business Quant, the three latest ONC Shares Outstanding figures stand at $1.0 billion (Q1 2020), $776.3 million (Q4 2018), and $701.6 million (Q2 2018).

Peer Comparison